Home / LPCN : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does LPCN make money? Does LPCN have pricing power? What's the Earnings Whisper? Will LPCN profit more as the business scales? What is LPCN's management track record? Is LPCN's current price justified?

Lipocine Inc.

$2.27 -$5.73 (-71.62%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$2.25

Day Range

$2.25$2.29

Year Range

$1.81$12.37

Market Cap

18.71M

AVG Volume

64.88K

Trailing/Forward PE

-1.21/-

PEG ratio

-0.19

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

NASDAQ

Revenue (USD)

LPCN Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	190.1K
26 Q1	119.4K
25 Q4	1.15M
25 Q3	114.57K
25 Q2	622.85K
25 Q1	93.86K
24 Q4	3.49M
24 Q3	0
24 Q2	89.56K
24 Q1	7.62M

Net Income (USD)

LPCN Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-2.62M
26 Q1	-3.67M
25 Q4	-2.37M
25 Q3	-3.19M
25 Q2	-2.21M
25 Q1	-1.86M
24 Q4	1.78M
24 Q3	-2.22M
24 Q2	-3.07M
24 Q1	3.51M

Operating Income (USD)

LPCN Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-2.84M
26 Q1	-3.85M
25 Q4	-2.52M
25 Q3	-3.36M
25 Q2	-2.4M
25 Q1	-2.09M
24 Q4	1.55M
24 Q3	-2.63M
24 Q2	-3.29M
24 Q1	3.22M

EBITDA (USD)

LPCN EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-2.61M
26 Q1	-3.66M
25 Q4	-2.36M
25 Q3	-3.17M
25 Q2	-2.19M
25 Q1	-1.85M
24 Q4	1.8M
24 Q3	-2.21M
24 Q2	-3.06M
24 Q1	3.52M

Cash Flows (USD)

LPCN Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-3.03M
26 Q1	-2.26M
25 Q4	-2.92M
25 Q3	-2.99M
25 Q2	-1.89M
25 Q1	-1.97M
24 Q4	1.69M
24 Q3	-2.91M
24 Q2	-2.5M
24 Q1	2.41M

EPS (USD)

LPCN EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.32
26 Q1	-0.54
25 Q4	-0.42
25 Q3	-0.59
25 Q2	-0.41
25 Q1	-0.35
24 Q4	0.32
24 Q3	-0.41
24 Q2	-0.57
24 Q1	0.66

Expenses (USD)

LPCN Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	3.03M
26 Q1	3.95M
25 Q4	3.68M
25 Q3	3.48M
25 Q2	3.01M
25 Q1	2.18M
24 Q4	1.96M
24 Q3	2.71M
24 Q2	1.51M
24 Q1	4.39M

Cash & Debt (USD)

LPCN Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	23.27M
26 Q1	24.73M
25 Q4	14.93M
25 Q3	15.13M
25 Q2	17.94M
25 Q1	19.72M
24 Q4	21.63M
24 Q3	19.82M
24 Q2	22.55M
24 Q1	24.63M

Debt ratios

LPCN Debt ratios by quarter
Period	Debt ratios
26 Q2	1.97
26 Q1	2.17
25 Q4	1.51
25 Q3	2.77
25 Q2	4.03
25 Q1	3.71
24 Q4	-431.47
24 Q3	4.93
24 Q2	2.67
24 Q1	2.76

Margins

LPCN Margins by quarter
Period	Margins
26 Q2	100%
26 Q1	87.59%
25 Q4	98.69%
25 Q3	100%
25 Q2	-243.06%
25 Q1	100%
24 Q4	100%
24 Q2	-1993.14%
24 Q1	100%
23 Q4	100%

Return on Capital

LPCN Return on Capital by quarter
Period	Return on Capital
26 Q2	-12.05%
26 Q1	-16.08%
25 Q4	-16.37%
25 Q3	-22.53%
25 Q2	-12.88%
25 Q1	-9.71%
24 Q4	8.49%
24 Q3	-11.61%
24 Q2	-14.47%
24 Q1	14.67%

Shares Outstanding

LPCN Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	8.22M
26 Q1	6.79M
25 Q4	5.45M
25 Q3	5.41M
25 Q2	5.35M
25 Q1	5.35M
24 Q4	5.34M
24 Q3	5.35M
24 Q2	5.34M
24 Q1	5.32M

Book Value Per Share (USD)

LPCN Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	2.65
26 Q1	3.36
25 Q4	2.66
25 Q3	2.61
25 Q2	3.2
25 Q1	3.59
24 Q4	3.93
24 Q3	3.57
24 Q2	3.97
24 Q1	4.51

Total Assets (USD)

LPCN Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	23.84M
26 Q1	25.36M
25 Q4	17.01M
25 Q3	16.07M
25 Q2	18.58M
25 Q1	20.5M
24 Q4	22.51M
24 Q3	20.7M
24 Q2	23.03M
24 Q1	25.45M

Employee Count

LPCN Employee Count by quarter
Period	Employee Count
2025	14
2024	16
2023	17
2022	17
2021	13
2020	11
2019	12
2018	10
2017	14
2016	14

PE Ratio

LPCN PE Ratio by quarter
Period	PE Ratio
May 25	2135.07
Apr 25	2039.18
Apr 25	1917.73
Apr 25	1962.48
Apr 25	1924.12
Mar 25	2096.72
Mar 25	2262.92
Mar 25	2141.46
Mar 23	8.42
Feb 23	8.25
Feb 23	9.6
Feb 23	10.15
Feb 23	10.56
Jan 23	10.27
Jan 23	10.37
Jan 23	10.67
Jan 23	9.21
Dec 22	7.64
Dec 22	7.79
Dec 22	8.16
Dec 22	7.78
Dec 22	8.64
Nov 22	9.16
Nov 22	9.21
Nov 22	7.32
Nov 22	8.47
Oct 22	8.84
Oct 22	9.44
Oct 22	9.63
Oct 22	9.74
Sep 22	9.63
Sep 22	10.63
Sep 22	12.13
Sep 22	11.03
Sep 22	12.2
Aug 22	12.52
Aug 22	13.05
Aug 22	15.1

Free Cash Flow Yield

LPCN Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-60%
Sep 26	-55.59%
Aug 26	-62.76%
Aug 26	-65.16%
Aug 26	-64.55%
Aug 26	-63.94%
Jul 26	-69.76%
Jul 26	-71.1%
Jul 26	-66.31%
Jul 26	-61.36%
Jul 26	-61.88%
Jun 26	-60.11%
Jun 26	-63.47%
Jun 26	-65.43%
Jun 26	-72.14%
May 26	-65.73%
May 26	-65.43%
May 26	-65.43%
May 26	-62.4%
May 26	-76.88%
Apr 26	-74.02%
Apr 26	-73.72%
Apr 26	-81.42%
Apr 26	-87.38%
Mar 26	-25.05%
Mar 26	-25.05%
Mar 26	-24.41%
Mar 26	-11.7%
Feb 26	-9.55%
Feb 26	-9.71%
Feb 26	-10.98%
Feb 26	-11.2%
Jan 26	-10.57%
Jan 26	-8.72%
Jan 26	-8.55%
Jan 26	-11.88%
Jan 26	-11.89%
Dec 25	-18.19%
Dec 25	-22.38%
Dec 25	-30.01%
Dec 25	-30.2%
Nov 25	-27.65%
Nov 25	-30.1%
Nov 25	-33.14%
Nov 25	-37.45%
Oct 25	-35.66%
Oct 25	-32.71%
Oct 25	-31.41%
Oct 25	-30.6%
Oct 25	-28.31%
Sep 25	-34.75%
Sep 25	-32.94%
Sep 25	-31.83%
Sep 25	-32.82%
Aug 25	-32.6%
Aug 25	-30.5%
Aug 25	-31.3%
Aug 25	-32.37%
Aug 25	-33.76%
Jul 25	-30.92%
Jul 25	-34.09%
Jul 25	-32.52%
Jul 25	-34.31%
Jun 25	-32.32%
Jun 25	-32.23%
Jun 25	-34.09%
Jun 25	-33.55%
May 25	-31.46%
May 25	-29.71%
May 25	-26.65%
May 25	-32.42%
May 25	-7.35%
Apr 25	-7.7%
Apr 25	-8.19%
Apr 25	-8%
Apr 25	-8.16%
Mar 25	-7.49%
Mar 25	-6.94%
Mar 25	-7.33%
Mar 25	-27.37%
Feb 25	-30.67%
Feb 25	-27.85%
Feb 25	-25.93%
Feb 25	-26.9%
Jan 25	-21.79%
Jan 25	-20.07%
Jan 25	-21.54%
Jan 25	-19.25%
Jan 25	-18.61%
Dec 24	-19.78%
Dec 24	-19.33%
Dec 24	-18.75%
Dec 24	-18.46%
Nov 24	-20.74%
Nov 24	-18.28%
Nov 24	-19.25%
Nov 24	-19.78%
Nov 24	-14.55%
Oct 24	-15.33%
Oct 24	-16.92%

Price to Sales

LPCN Price to Sales by quarter
Period	Price to Sales
Sep 26	11.88
Sep 26	12.83
Aug 26	11.36
Aug 26	10.94
Aug 26	11.05
Aug 26	11.15
Jul 26	7.19
Jul 26	7.06
Jul 26	7.57
Jul 26	8.18
Jul 26	8.11
Jun 26	8.35
Jun 26	7.91
Jun 26	7.67
Jun 26	6.96
May 26	7.64
May 26	7.67
May 26	7.67
May 26	8.04
May 26	6.42
Apr 26	6.67
Apr 26	6.7
Apr 26	6.06
Apr 26	5.65
Mar 26	19.71
Mar 26	19.71
Mar 26	20.23
Mar 26	10.18
Feb 26	12.47
Feb 26	12.27
Feb 26	10.84
Feb 26	10.63
Jan 26	11.27
Jan 26	13.66
Jan 26	13.94
Jan 26	10.03
Jan 26	10.02
Dec 25	6.55
Dec 25	5.32
Dec 25	3.97
Dec 25	3.94
Nov 25	4.31
Nov 25	3.96
Nov 25	3.59
Nov 25	3.18
Oct 25	3.38
Oct 25	3.69
Oct 25	3.84
Oct 25	3.94
Oct 25	4.26
Sep 25	3.47
Sep 25	3.66
Sep 25	3.79
Sep 25	3.68
Aug 25	3.7
Aug 25	3.96
Aug 25	3.85
Aug 25	3.73
Aug 25	4.58
Jul 25	5.01
Jul 25	4.54
Jul 25	4.76
Jul 25	4.51
Jun 25	4.79
Jun 25	4.8
Jun 25	4.54
Jun 25	4.61
May 25	4.92
May 25	5.21
May 25	5.81
May 25	4.77
May 25	1.59
Apr 25	1.52
Apr 25	1.43
Apr 25	1.46
Apr 25	1.44
Mar 25	1.56
Mar 25	1.69
Mar 25	1.6
Mar 25	2.32
Feb 25	2.07
Feb 25	2.28
Feb 25	2.45
Feb 25	2.36
Jan 25	2.92
Jan 25	3.17
Jan 25	2.95
Jan 25	3.3
Jan 25	3.42
Dec 24	3.21
Dec 24	3.29
Dec 24	3.39
Dec 24	3.44
Nov 24	3.06
Nov 24	3.48
Nov 24	3.3
Nov 24	3.21
Nov 24	6.77
Oct 24	6.42
Oct 24	5.82

EV/EBITDA

LPCN EV/EBITDA by quarter
Period	EV/EBITDA
May 25	-75.81
Apr 25	-91.79
Apr 25	-112.02
Apr 25	-104.56
Apr 25	-110.95
Mar 25	-82.2
Mar 25	-54.52
Mar 25	-74.75
Mar 23	0.06
Feb 23	-0.11
Feb 23	1.21
Feb 23	1.76
Feb 23	2.16
Jan 23	1.88
Jan 23	1.97
Jan 23	2.27
Jan 23	0.84
Dec 22	-0.71
Dec 22	-0.56
Dec 22	-0.2
Dec 22	-0.58
Dec 22	0.27
Nov 22	0.78
Nov 22	0.84
Nov 22	-1.03
Nov 22	-2.38
Oct 22	-2.02
Oct 22	-1.44
Oct 22	-1.26
Oct 22	-1.15
Sep 22	-1.26
Sep 22	-0.28
Sep 22	1.17
Sep 22	0.1
Sep 22	1.23
Aug 22	1.55
Aug 22	2.06
Aug 22	4.05

Price to Book

LPCN Price to Book by quarter
Period	Price to Book
Sep 26	0.86
Sep 26	0.92
Aug 26	0.82
Aug 26	0.79
Aug 26	0.8
Aug 26	0.8
Jul 26	0.63
Jul 26	0.62
Jul 26	0.66
Jul 26	0.72
Jul 26	0.71
Jun 26	0.73
Jun 26	0.69
Jun 26	0.67
Jun 26	0.61
May 26	0.67
May 26	0.67
May 26	0.67
May 26	0.71
May 26	0.88
Apr 26	0.91
Apr 26	0.91
Apr 26	0.83
Apr 26	0.77
Mar 26	2.69
Mar 26	2.69
Mar 26	2.76
Mar 26	3.11
Feb 26	3.81
Feb 26	3.75
Feb 26	3.31
Feb 26	3.25
Jan 26	3.44
Jan 26	4.18
Jan 26	4.26
Jan 26	3.07
Jan 26	3.06
Dec 25	2
Dec 25	1.63
Dec 25	1.21
Dec 25	1.21
Nov 25	1.32
Nov 25	1.21
Nov 25	1.1
Nov 25	0.97
Oct 25	0.83
Oct 25	0.91
Oct 25	0.94
Oct 25	0.97
Oct 25	1.05
Sep 25	0.85
Sep 25	0.9
Sep 25	0.93
Sep 25	0.9
Aug 25	0.91
Aug 25	0.97
Aug 25	0.95
Aug 25	0.92
Aug 25	0.88
Jul 25	0.96
Jul 25	0.87
Jul 25	0.91
Jul 25	0.86
Jun 25	0.92
Jun 25	0.92
Jun 25	0.87
Jun 25	0.88
May 25	0.94
May 25	1
May 25	1.11
May 25	0.91
May 25	0.85
Apr 25	0.81
Apr 25	0.76
Apr 25	0.78
Apr 25	0.77
Mar 25	0.83
Mar 25	0.9
Mar 25	0.85
Mar 25	0.96
Feb 25	0.86
Feb 25	0.95
Feb 25	1.02
Feb 25	0.98
Jan 25	1.21
Jan 25	1.31
Jan 25	1.22
Jan 25	1.37
Jan 25	1.42
Dec 24	1.33
Dec 24	1.36
Dec 24	1.4
Dec 24	1.43
Nov 24	1.27
Nov 24	1.44
Nov 24	1.37
Nov 24	1.33
Nov 24	1.53
Oct 24	1.45
Oct 24	1.32

No video analysis for this stock yet. Request one from our team.

News: LPCN

prnewswire.com · 10 Sep 2026

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company management will present and meet with investors at the H.C.

prnewswire.com · 4 Aug 2026

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026

SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced financial results for the second quarter ended June 30, 2026 and provided a corporate update. Recent Developments and Corporate Update LPCN 1154 (BRLIZIO™) for Postpartum Depression (PPD) On April 2, 2026, Lipocine reported topline results from its Phase 3 placebo-controlled trial (N=90) evaluating oral LPCN 1154 (oral brexanolone) for the treatment of PPD.

prnewswire.com · 3 Aug 2026

Lipocine Appoints Michael J. Grissinger to Board of Directors

SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the appointment of Michael J. Grissinger to its Board of Directors, effective August 3, 2026.